NJ Biopharmaceuticals is a CRO (contract research organization) that provides integrated chemistry and biology services. It offers antibody-drug conjugates, nucleotide and oligonucleotide synthesis, multi-step organic synthesis, flow chemistry-based process development, etc. The company serves biopharmaceutical and chemistry-based technology companies.